ClinicalTrials.gov
public full text
Public Domain
A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD)
The purpose of this proof-of-concept trial is to examine the safety, tolerability, and pharmacokinetics (PK), and preliminary clinical efficacy of CYB004 participants with GAD.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety#840959
- Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use#966722
- Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and Depression#1212004
- A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive Disorder#1352330
- CannaRiver CBD Calm for Anxiety, Sleep, and Well-Being in Adults With Generalized Anxiety Disorder#982650
Record · ID 1398217
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive